Geode Capital Management
TYRA icon

Geode Capital Management’s Tyra Biosciences TYRA Stock Holding History

Geode Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31M Buy
970,734
+312,252
+47% +$10.3M ﹤0.01% 1906
2026
Q1 		$25.2M Buy
658,482
+726
+0.1% +$23.5K ﹤0.01% 1872
2025
Q4 		$17.3M Buy
657,756
+60,302
+10% +$1.11M ﹤0.01% 2092
2025
Q3 		$8.36M Buy
597,454
+30,328
+5% +$346K ﹤0.01% 2515
2025
Q2 		$5.43M Buy
567,126
+50,836
+10% +$483K ﹤0.01% 2685
2025
Q1 		$4.8M Sell
516,290
-1,288
-0.2% -$16.7K ﹤0.01% 2675
2024
Q4 		$7.2M Sell
517,578
-5,612
-1% -$102K ﹤0.01% 2550
2024
Q3 		$12.3M Buy
523,190
+516
+0.1% +$10.8K ﹤0.01% 2261
2024
Q2 		$8.36M Buy
522,674
+105,866
+25% +$1.82M ﹤0.01% 2436
2024
Q1 		$6.84M Buy
416,808
+83,339
+25% +$1.37M ﹤0.01% 2534
2023
Q4 		$4.62M Buy
333,469
+18,991
+6% +$246K ﹤0.01% 2746
2023
Q3 		$4.33M Buy
314,478
+24,480
+8% +$363K ﹤0.01% 2716
2023
Q2 		$4.94M Buy
289,998
+3,894
+1% +$56.5K ﹤0.01% 2679
2023
Q1 		$4.6M Buy
286,104
+32,412
+13% +$386K ﹤0.01% 2665
2022
Q4 		$1.93M Buy
253,692
+6,242
+3% +$44.1K ﹤0.01% 3057
2022
Q3 		$2.17M Buy
247,450
+22,039
+10% +$202K ﹤0.01% 3058
2022
Q2 		$1.61M Buy
225,411
+14,862
+7% +$118K ﹤0.01% 3192
2022
Q1 		$2.25M Buy
210,549
+4,168
+2% +$49.5K ﹤0.01% 3206
2021
Q4 		$2.9M Buy
+206,381
New +$4.1M ﹤0.01% 3187

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Geode Capital Management's TYRA Position: Q2 2026 in Review

Geode Capital Management increased its Tyra Biosciences (TYRA) stake by 47% in Q2 2026, buying an estimated $10.3M and bringing the position to 970,734 shares worth $31M. The position accounts for ﹤0.01% of the portfolio, ranked #1906.

Geode Capital Management first reported a position in TYRA in Q4 2021 and has held it in 19 quarters since. 170 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Geode Capital Management held 970,734 shares of Tyra Biosciences worth $31M as of Q2 2026.
  • Geode Capital Management bought 312,252 Tyra Biosciences shares in Q2 2026, an estimated $10.3M.
  • Tyra Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1906 holding.
  • Geode Capital Management first reported a position in Tyra Biosciences in Q4 2021 and has held it in 19 quarters since.
  • 170 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.